Amicus Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Amicus Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Amicus Therapeutics Inc Strategy Report
- Understand Amicus Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company, which discovers, develops, and commercializes small molecule drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. The company focus on R&D, proprietary technology, and improvement in Galafold's revenue are its strengths even as operating loss carryforward could be a major cause for concern to the company. Amicus Therapeutics could benefit from the unmet medical need of Fabry disease, market potential of Galafold, and breakthrough therapy designation. However, its performance could be affected by competitive environment, uncertainties in R&D, and stringent government regulations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer